Funds breakthrough cancer research to tackle over 200 types of cancer and double UK survival rates.
Cancer Research UK: Funds breakthrough cancer research to tackle over 200 types of… · Jun 14–Jul 12, 2026
ActiveCancer Research UK's campaign highlights their innovative scientific research, including insights from unexpected sources like Greenland sharks, to find new ways to tackle over 200 types of cancer and improve survival rates.
13-week activity
Public campaign reads by observed week
Renewal signals
No recurring promo code was observed.
Their work has helped to double survival in The UK over the last fifty years and continues to save and improve lives around the world.
Shows
Where the campaign appearedPlacements
Categories
Representative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
Answers. Or do I? This episode is brought to you by Cancer Research UK. Scientists have found that cancer risks usually increase with age and size, but some species defy the odds. For example, deep sea Greenland sharks. They can grow over six meters long, weigh more than a small car, and yet live for up to four hundred years. Now understanding how Greenland Shark's cellular repair and immune systems seem to have managed to keep them cancer free for centuries, that could open up exciting research pathways. Essentially, over millions of years, evolution has been running the world's most successful cancer prevention trial. And sometimes, breakthroughs can be found in unusual places. So by exploring the unexpected, Cancer Research UK scientists are uncovering new ways to tackle over 200 types of cancer. Their work has helped to double survival in The UK over the last fifty years and continues to save and improve lives around the world. For more information about Cancer Research UK, their research and breakthroughs, and how you can support them, visit cancer research u k dot org slash the rest is
More campaigns from Cancer Research UK
Other published campaigns from this sponsor
The campaign highlights Cancer Research UK's pioneering work in immunotherapy, specifically CAR T-cell therapy for blood cancers and solid tumors, and its historical contribution to doubling cancer survival in the UK.
Cancer Research UK advertising observed across this podcast campaign.
Cancer Research UK advertising observed across this podcast campaign.
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.